Fisher & Paykel Healthcare Corporation Limited Stock
Equities
FPH
NZFAPE0001S2
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.90 NZD | +0.19% |
|
-0.76% | -1.30% |
| Dec. 11 | NZX Midday Sector Update: Consumer Durables Soar, Health Technology Struggles | MT |
| Dec. 04 | NZX Biggest Losers | MT |
| Capitalization | 22.26B 12.9B 10.95B 10.25B 9.6B 17.72B 1,172B 19.43B 120B 46.18B 551B 48.37B 47.36B 1,996B | P/E ratio 2026 * |
49.4x | P/E ratio 2027 * | 42.3x |
|---|---|---|---|---|---|
| Enterprise value | 22.01B 12.75B 10.83B 10.13B 9.5B 17.53B 1,159B 19.21B 118B 45.66B 545B 47.83B 46.83B 1,974B | EV / Sales 2026 * |
9.75x | EV / Sales 2027 * | 8.69x |
| Free-Float |
91.76% | Yield 2026 * |
1.26% | Yield 2027 * | 1.53% |
Last Transcript: Fisher & Paykel Healthcare Corporation Limited
| 1 day | +0.19% | ||
| 1 week | -0.76% | ||
| Current month | +1.61% | ||
| 1 month | +0.56% | ||
| 3 months | +0.53% | ||
| 6 months | +3.55% | ||
| Current year | -1.30% |
| 1 week | 37.3 | 38.49 | |
| 1 month | 36.21 | 40.46 | |
| Current year | 31.8 | 40.46 | |
| 1 year | 31.8 | 40.46 | |
| 3 years | 20.29 | 40.46 | |
| 5 years | 18.02 | 40.46 | |
| 10 years | 8.13 | 40.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lewis Gradon
CEO | Chief Executive Officer | 64 | 2016-03-31 |
Lyndal York
DFI | Director of Finance/CFO | - | 2018-10-22 |
Andy Niccol
COO | Chief Operating Officer | - | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Daniell
BRD | Director/Board Member | 67 | 2001-10-31 |
Lewis Gradon
BRD | Director/Board Member | 64 | 2016-03-31 |
| Director/Board Member | - | 2017-05-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.19% | -0.76% | +2.99% | +64.64% | 12.88B | ||
| -0.95% | +5.06% | +13.11% | +19.16% | 223B | ||
| -0.82% | -1.83% | +20.21% | +27.47% | 126B | ||
| -2.44% | +1.19% | +48.52% | +104.64% | 67.96B | ||
| -1.56% | +4.36% | -13.41% | -21.03% | 57.11B | ||
| -0.29% | +0.31% | +19.23% | +70.27% | 52.41B | ||
| +0.05% | -0.70% | -13.80% | -42.54% | 25.64B | ||
| -0.90% | -1.96% | +19.52% | +37.81% | 24.94B | ||
| +0.48% | +0.10% | +8.69% | -31.46% | 23.72B | ||
| +1.18% | -2.22% | -24.06% | +15.07% | 21.76B | ||
| Average | -0.50% | +0.45% | +8.10% | +24.40% | 63.62B | |
| Weighted average by Cap. | -0.89% | +1.96% | +13.95% | +27.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.26B 1.31B 1.11B 1.04B 974M 1.8B 119B 1.97B 12.14B 4.69B 55.88B 4.91B 4.81B 203B | 2.52B 1.46B 1.24B 1.16B 1.09B 2.01B 133B 2.2B 13.54B 5.22B 62.31B 5.47B 5.36B 226B |
| Net income | 452M 262M 222M 208M 195M 360M 23.81B 395M 2.43B 938M 11.19B 982M 962M 40.55B | 527M 305M 259M 243M 227M 420M 27.76B 460M 2.83B 1.09B 13.04B 1.15B 1.12B 47.28B |
| Net Debt | -248M -144M -122M -114M -107M -198M -13.07B -217M -1.33B -515M -6.14B -539M -528M -22.26B | -367M -213M -181M -169M -158M -292M -19.34B -320M -1.97B -762M -9.08B -798M -781M -32.93B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-15 | 37.90 $ | +0.19% | 393,153 |
| 25-12-15 | 37.83 $ | +1.04% | 377,681 |
| 25-12-12 | 37.44 $ | -1.47% | 300,469 |
| 25-12-11 | 38.00 $ | +0.29% | 441,621 |
| 25-12-10 | 37.89 $ | -0.45% | 557,187 |
End-of-day quote New Zealand S.E., December 15, 2025
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FPH Stock
Select your edition
All financial news and data tailored to specific country editions
















